Astellas Pharma US has announced the Food and Drug Administration's approval to review the new drug application for tacrolimus extended-release capsules.
The U.S. subsidiary of Japanese drug maker Astellas is seeking approval from the Food and Drug Administration for a drug to prevent rejection of transplanted organs.
Schnuck Markets is opening a stand-alone pharmacy at a hospital in Illinois with an emphasis on specialty pharmacy services, the supermarket operator said.